Granulomatosis with Polyangiitis

"Granulomatosis with Polyangiitis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN.

Descriptor ID	D014890
MeSH Number(s)	C08.381.483.950 C14.907.940.897.249.750 C20.111.193.875
Concept/Terms	Granulomatosis with Polyangiitis Granulomatosis with Polyangiitis Granulomatosis with Polyangiitides Polyangiitides, Granulomatosis with Polyangiitis, Granulomatosis with with Polyangiitides, Granulomatosis with Polyangiitis, Granulomatosis Wegener Granulomatosis Granulomatosis, Wegener Wegener's Granulomatosis Granulomatosis, Wegener's

Below are MeSH descriptors whose meaning is more general than "Granulomatosis with Polyangiitis".

Diseases [C]
Respiratory Tract Diseases [C08]
Lung Diseases [C08.381]
Lung Diseases, Interstitial [C08.381.483]
Granulomatosis with Polyangiitis [C08.381.483.950]
Cardiovascular Diseases [C14]
Vascular Diseases [C14.907]
Vasculitis [C14.907.940]
Systemic Vasculitis [C14.907.940.897]
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis [C14.907.940.897.249]
Granulomatosis with Polyangiitis [C14.907.940.897.249.750]
Immune System Diseases [C20]
Autoimmune Diseases [C20.111]
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis [C20.111.193]
Granulomatosis with Polyangiitis [C20.111.193.875]

Below are MeSH descriptors whose meaning is related to "Granulomatosis with Polyangiitis".

Below are MeSH descriptors whose meaning is more specific than "Granulomatosis with Polyangiitis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Granulomatosis with Polyangiitis" by people in this website by year, and whether "Granulomatosis with Polyangiitis" was a major or minor topic of these publications.

Bar chart showing 13 publications over 11 distinct years, with a maximum of 3 publications in 2002

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
2001	0	1	1
2002	1	2	3
2003	0	1	1
2005	1	0	1
2006	1	0	1
2009	1	0	1
2010	0	1	1
2011	1	0	1
2018	1	0	1
2023	1	0	1

Below are the most recent publications written about "Granulomatosis with Polyangiitis" by people in Profiles.

Cao B, Hogan SL, Derebail VK, Ehlert A, Thorpe CT. Polypharmacy in US Medicare beneficiaries with antineutrophil cytoplasmic antibody vasculitis. J Manag Care Spec Pharm. 2023 Jul; 29(7):770-781.

View in: PubMed
Wallace ZS, Wallwork R, Zhang Y, Lu N, Cortazar F, Niles JL, Heher E, Stone JH, Choi HK. Improved survival with renal transplantation for end-stage renal disease due to granulomatosis with polyangiitis: data from the United States Renal Data System. Ann Rheum Dis. 2018 09; 77(9):1333-1338.

View in: PubMed
Cao Y, Schmitz JL, Yang J, Hogan SL, Bunch D, Hu Y, Jennette CE, Berg EA, Arnett FC, Jennette JC, Falk RJ, Preston GA. DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans. J Am Soc Nephrol. 2011 Jun; 22(6):1161-7.

View in: PubMed
Tomasson G, Lavalley M, Tanriverdi K, Finkielman JD, Davis JC, Hoffman GS, McCune WJ, St Clair EW, Specks U, Spiera R, Stone JH, Freedman JE, Merkel PA. Relationship between markers of platelet activation and inflammation with disease activity in Wegener's granulomatosis. J Rheumatol. 2011 Jun; 38(6):1048-54.

View in: PubMed
Kang J, Litmanovich D, Bankier AA, Boiselle PM, Eisenberg RL. Manifestations of systemic diseases on thoracic imaging. Curr Probl Diagn Radiol. 2010 Nov-Dec; 39(6):247-61.

View in: PubMed
Carpenter DM, Thorpe CT, Lewis M, Devellis RF, Hogan SL. Health-related quality of life for patients with vasculitis and their spouses. Arthritis Rheum. 2009 Feb 15; 61(2):259-65.

View in: PubMed
Sarraf P, Kay J, Friday RP, Reginato AM. Wegener's granulomatosis: is biologic therapy useful? Curr Rheumatol Rep. 2006 Aug; 8(4):303-11.

View in: PubMed
Joy MS, Hogan SL, Jennette JC, Falk RJ, Nachman PH. A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis. Nephrol Dial Transplant. 2005 Dec; 20(12):2725-32.

View in: PubMed
Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis. 2003 Dec; 42(6):1149-53.

View in: PubMed
Yang JJ, Preston GA, Alcorta DA, Waga I, Munger WE, Hogan SL, Sekura SB, Phillips BD, Thomas RP, Jennette JC, Falk RJ. Expression profile of leukocyte genes activated by anti-neutrophil cytoplasmic autoantibodies (ANCA). Kidney Int. 2002 Nov; 62(5):1638-49.

View in: PubMed

People

Explore

Similar Concepts

Top Journals